Showing 201 - 220 results of 238 for search 'The Four Companions', query time: 0.09s Refine Results
  1. 201
  2. 202

    The Sunburst Arc with JWST. III. An Abundance of Direct Chemical Abundances by Brian Welch, T. Emil Rivera-Thorsen, Jane R. Rigby, Taylor A. Hutchison, Grace M. Olivier, Danielle A. Berg, Keren Sharon, Håkon Dahle, M. Riley Owens, Matthew B. Bayliss, Gourav Khullar, John Chisholm, Matthew Hayes, Keunho J. Kim

    Published 2025-01-01
    “…We also detect the density-sensitive doublets of [O ii ] λλ 3727, 3730, [S ii ] λλ 6718, 6733, and [Ar iv ] λλ 4713, 4741, which constrain the density in both the low- and high-ionization gas. …”
    Get full text
    Article
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Iron(III)–Quercetin Complex: In Vivo Acute Toxicity and Biodistribution of Novel MRI Agent by Innuan P, Kongkarnka S, Thongtharb A, Kantapan J, Dechsupa N

    Published 2025-01-01
    “…Phattarawadee Innuan,1,2 Sarawut Kongkarnka,3 Atigan Thongtharb,4 Jiraporn Kantapan,1,2 Nathupakorn Dechsupa1,2 1Molecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand; 2Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand; 3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand; 4Department of Companion Animal and Wildlife Clinic, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, 50100, ThailandCorrespondence: Nathupakorn Dechsupa; Jiraporn Kantapan, Molecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand, Email nathupakorn.d@cmu.ac.th; Jiraporn.kan@cmu.ac.thBackground: The iron(III)–quercetin complex, known as “IronQ”, is an innovative MRI contrast agent composed of one Fe(III) ion and two quercetin molecules. …”
    Get full text
    Article
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219

    Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types by Jeffrey S Ross, Richard S P Huang, Jake G Maule, Lani K Clinton, Ryon P Graf, Jinpeng Xiao, Geoffrey R Oxnard

    Published 2022-10-01
    “…The same PD-L1 status with all three antibody clones was observed in 48.7% (97/199) of NSCLC cases, and among these, 54.6% (53/97) were triple negative and 45.4% (44/97) triple positive. A total of 73.4% (146/199) NSCLC cases were positive with at least one IHC assay (95.2% (n=139/146), 82.2% (n=120/146), and 32.2% (n=47/146) were positive for 22C3, 28-8, and SP142, respectively). …”
    Get full text
    Article
  20. 220